Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  DietMedicationType 2 DiabetesPrediabetesIssue 700

High Magnesium Intake May Offset Risk of Developing Diabetes

Magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk....
Advertisement

In this study, Hurby et al examined 7-yr associations between magnesium intake and the incidence of prediabetes and/or insulin resistance, and progression from these states to type 2 diabetes. A total of 2,582 participants ages 26–81 years old at baseline were selected. Magnesium intake and risk of metabolic impairment, defined as impaired fasting glucose (≥5.6–<7.0 mmol/L), impaired glucose tolerance (2-hr postload glucose ≥7.8–<11.1 mmol/L), insulin resistance, or hyperinsulinemia (≥90th percentile of HOMA-IR or fasting insulin, respectively), was estimated among those with normal baseline status. The risk of incident diabetes was estimated among those with baseline metabolic impairment. In participants without incident diabetes, the authors examined magnesium intake in relation to 7-yr changes in fasting and postload glucose and insulin, insulin resistance, and insulin sensitivity.

After adjusting for age, sex, and energy intake, compared to those with the lowest magnesium intake, those with the highest intake had 37% lower risk of incident metabolic impairment. For those with baseline metabolic impairment, higher intake was associated with a 32% lower risk of incident diabetes. In the combined population, the risk in those with the highest intake was 53% compared to those with the lowest intake of magnesium. Adjusting for risk factors and dietary fiber attenuated associations in the baseline normal population, but did not substantially affect associations in the metabolically impaired.

Higher magnesium intake tended to associate with lower follow-up fasting glucose and IR, but not fasting insulin, postload values, or insulin sensitivity. As a result, the authors concluded that magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk.

Practice Pearls:
  • Magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk.
  • Those with the highest intake had 37% lower risk of incident metabolic impairment.

Diabetes Care, October 2013 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 25 October, 2013 and appeared in  DietMedicationType 2 DiabetesPrediabetesIssue 700

Past five issues: Issue 757 | Diabetes Clinical Mastery Series Issue 216 | Issue 756 | Diabetes Clinical Mastery Series Issue 215 | SGLT-2 Inhibitors Special Edition November 2014 |

2014 Most Popular Articles:

New SGLT2 Inhibitor Likely To Be Approved for Type 2 Diabetes
Posted November 14, 2014
New Approach Targets Type 2's Poorly Controlled With Metformin
Posted November 14, 2014
Very Low Carbohydrate, Low Saturated Fat Diet for Type 2 Diabetes Management
Posted November 07, 2014
Exercise Promotes Preservation of Beta Cells
Posted November 14, 2014
Dietary Magnesium Intake's Role in Decreasing Metabolic Syndrome
Posted October 31, 2014
Handbook of Diabetes, 4th Ed., Excerpt #18: Hypertension in Diabetes
Posted November 16, 2014
Handbook of Diabetes, 4th Ed., Excerpt #16: Diabetic Neuropathy
Posted November 02, 2014
Grapefruit Juice May Affect Insulin Resistance
Posted October 23, 2014
Is Type 2 Diabetes an Inflammatory Disease?
Posted November 21, 2014
Verapamil Studied in Prevention, Development of Diabetes
Posted November 14, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients should be on insulin but refuse?
CME/CE of the Week
Hope Warshaw, MMSc, RD, CDE

Category: Nutrition
Credits: 1.25
Search Articles On Diabetes In Control